Cambridge, MA · Founded 2021 · Privately Held (backing)
Operator of a biotech company intended to treat patients with blood, bone marrow, immune, and metabolic diseases. Stratus Therapeutics is based in Cambridge, MA and was founded in 2021. Its last reported valuation was $210 million in Jan 2023. It has raised $184 million.
Last reported valuation
$210.0M
Oct 2026
Priced at
—
Total raised
$184.1M
Last round
—
Cap table — not yet on record
Stratus Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Stratus Therapeutics with a free account
·The complete investor list: 13 names
·Watch Stratus Therapeutics: the Monday email on marks, rounds and moves
